Saatchi Kuwelker1, David O Prichard1, Kent Bailey2, Adil E Bharucha1. 1. Division of Gastroenterology and Hepatology, Clinical Enteric Neuroscience Translational and Epidemiological Research Program, Mayo Clinic, Rochester, MN, USA. 2. Division of Biostatistics, Mayo Clinic, Rochester, MN, USA.
Abstract
AIMS: Gastric emptying is of limited utility for predicting the severity of symptoms in patients with diabetes mellitus and gastrointestinal symptoms. We evaluated the extent to which symptoms recorded during a 13 C-spirulina-based gastric emptying breath test (GEBT) or scintigraphy predicting the severity of daily symptoms in diabetes mellitus. METHODS: Gastric emptying, symptoms during a gastric emptying study, either scintigraphy (n = 38) or GEBT (n = 111), and daily gastrointestinal symptoms were evaluated in 149 patients with diabetes mellitus and variably severe gastrointestinal symptoms. KEY RESULTS: Gastric emptying was normal, delayed, and rapid in 37%, 52%, and 9% measured with the GEBT and 55%, 34%, and 11% of patients measured with scintigraphy; differences between GEBT and scintigraphy were not significant. Daily symptoms were moderately severe or more intense in 58% and 21% of patients undergoing scintigraphy and GEBT (P < 0.0001). Symptoms during the GEBT (46%) and emptying thalf (3%) explained 50% of the variance in daily symptoms in the GEBT group. In the scintigraphy group, symptoms explained 29% of this variance; the thalf was insignificant. Patients who reported that one or more symptoms were more severe than the others during the GE study were more likely (OR 3.98, 95% CI 2.16, 7.33) to report the same symptom(s) as being the most severe in the daily diary. CONCLUSIONS: Symptoms during a GEBT and to a lesser extent during scintigraphy, but not gastric emptying predict the severity of daily symptoms and may serve as a biomarker in patients with diabetes mellitus.
AIMS: Gastric emptying is of limited utility for predicting the severity of symptoms in patients with diabetes mellitus and gastrointestinal symptoms. We evaluated the extent to which symptoms recorded during a 13 C-spirulina-based gastric emptying breath test (GEBT) or scintigraphy predicting the severity of daily symptoms in diabetes mellitus. METHODS: Gastric emptying, symptoms during a gastric emptying study, either scintigraphy (n = 38) or GEBT (n = 111), and daily gastrointestinal symptoms were evaluated in 149 patients with diabetes mellitus and variably severe gastrointestinal symptoms. KEY RESULTS: Gastric emptying was normal, delayed, and rapid in 37%, 52%, and 9% measured with the GEBT and 55%, 34%, and 11% of patients measured with scintigraphy; differences between GEBT and scintigraphy were not significant. Daily symptoms were moderately severe or more intense in 58% and 21% of patients undergoing scintigraphy and GEBT (P < 0.0001). Symptoms during the GEBT (46%) and emptying thalf (3%) explained 50% of the variance in daily symptoms in the GEBT group. In the scintigraphy group, symptoms explained 29% of this variance; the thalf was insignificant. Patients who reported that one or more symptoms were more severe than the others during the GE study were more likely (OR 3.98, 95% CI 2.16, 7.33) to report the same symptom(s) as being the most severe in the daily diary. CONCLUSIONS: Symptoms during a GEBT and to a lesser extent during scintigraphy, but not gastric emptying predict the severity of daily symptoms and may serve as a biomarker in patients with diabetes mellitus.
Authors: Lawrence A Szarka; Michael Camilleri; Adrian Vella; Duane Burton; Kari Baxter; Julie Simonson; Alan R Zinsmeister Journal: Clin Gastroenterol Hepatol Date: 2008-04-14 Impact factor: 11.382
Authors: Adil E Bharucha; Michael Camilleri; Duane D Burton; Shannon L Thieke; Kelly J Feuerhak; Ananda Basu; Alan R Zinsmeister Journal: Am J Gastroenterol Date: 2014-11-18 Impact factor: 10.864
Authors: Anshuman Desai; Phillip A Low; Michael Camilleri; Wolfgang Singer; Duane Burton; Subhankar Chakraborty; Adil E Bharucha Journal: Neurogastroenterol Motil Date: 2019-10-22 Impact factor: 3.598
Authors: Adil E Bharucha; Yogish Kudva; Ananda Basu; Michael Camilleri; Phillip A Low; Adrian Vella; Alan R Zinsmeister Journal: Clin Gastroenterol Hepatol Date: 2014-07-17 Impact factor: 11.382
Authors: Priya Vijayvargiya; Sina Jameie-Oskooei; Michael Camilleri; Victor Chedid; Patricia J Erwin; Mohammad Hassan Murad Journal: Gut Date: 2018-06-02 Impact factor: 23.059
Authors: Michael Camilleri; Richard W McCallum; Jan Tack; Sharon C Spence; Keith Gottesdiener; Fred T Fiedorek Journal: Gastroenterology Date: 2017-07-29 Impact factor: 22.682
Authors: Henry P Parkman; Mark L Van Natta; Alan H Maurer; Kenneth L Koch; Madhusudan Grover; Zubair Malik; Irene Sarosiek; Thomas L Abell; Robert Bulat; Braden Kuo; Robert J Shulman; Gianrico Farrugia; Laura Miriel; James Tonascia; Frank Hamilton; Pankaj J Pasricha; Richard W McCallum Journal: Am J Physiol Gastrointest Liver Physiol Date: 2022-05-03 Impact factor: 4.871
Authors: Gabrielle Sebaratnam; Nikita Karulkar; Stefan Calder; Jonathan S T Woodhead; Celia Keane; Daniel A Carson; Chris Varghese; Peng Du; Stephen J Waite; Jan Tack; Christopher N Andrews; Elizabeth Broadbent; Armen A Gharibans; Greg O'Grady Journal: Neurogastroenterol Motil Date: 2022-02-13 Impact factor: 3.960